Your browser doesn't support javascript.
loading
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.
Malcovati, Luca; Stevenson, Kristen; Papaemmanuil, Elli; Neuberg, Donna; Bejar, Rafael; Boultwood, Jacqueline; Bowen, David T; Campbell, Peter J; Ebert, Benjamin L; Fenaux, Pierre; Haferlach, Torsten; Heuser, Michael; Jansen, Joop H; Komrokji, Rami S; Maciejewski, Jaroslaw P; Walter, Matthew J; Fontenay, Michaela; Garcia-Manero, Guillermo; Graubert, Timothy A; Karsan, Aly; Meggendorfer, Manja; Pellagatti, Andrea; Sallman, David A; Savona, Michael R; Sekeres, Mikkael A; Steensma, David P; Tauro, Sudhir; Thol, Felicitas; Vyas, Paresh; Van de Loosdrecht, Arjan A; Haase, Detlef; Tüchler, Heinz; Greenberg, Peter L; Ogawa, Seishi; Hellstrom-Lindberg, Eva; Cazzola, Mario.
Afiliação
  • Malcovati L; Department of Molecular Medicine, University of Pavia & Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Stevenson K; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.
  • Papaemmanuil E; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Neuberg D; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.
  • Bejar R; UC San Diego Moores Cancer Center, La Jolla, CA.
  • Boultwood J; Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Bowen DT; St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom.
  • Campbell PJ; Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Ebert BL; Dana-Farber Cancer Institute, Boston, MA.
  • Fenaux P; Hôpital St Louis, Assistance Publique-Hôpitaux de Paris and Paris Diderot University, Paris, France.
  • Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Heuser M; Hannover Medical School, Hannover, Germany.
  • Jansen JH; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Komrokji RS; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Maciejewski JP; Cleveland Clinic Taussig Cancer Center, Cleveland, OH.
  • Walter MJ; Washington University School of Medicine, St. Louis, MO.
  • Fontenay M; Université Paris Descartes, Hôpital Cochin Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Garcia-Manero G; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Graubert TA; Massachusetts General Hospital Cancer Center, Boston, MA.
  • Karsan A; BC Cancer Research Centre & Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Pellagatti A; Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Sallman DA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Savona MR; Vanderbilt-Ingram Cancer Center, Nashville, TN.
  • Sekeres MA; Cleveland Clinic Taussig Cancer Center, Cleveland, OH.
  • Steensma DP; Dana-Farber Cancer Institute, Boston, MA.
  • Tauro S; Dundee Cancer Centre, University of Dundee, Ninewells Hospital, Dundee, United Kingdom.
  • Thol F; Hannover Medical School, Hannover, Germany.
  • Vyas P; MRC Molecular Hematology Unit, WIMM University of Oxford, Oxford Biomedical Research Centre, Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Van de Loosdrecht AA; Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Haase D; University Medical Center, Georg August University, Göttingen, Germany.
  • Tüchler H; Ludwig Boltzmann Institute for Leukemia Research, Vienna, Austria.
  • Greenberg PL; Stanford University Cancer Institute, Stanford, CA.
  • Ogawa S; Department of Tumor Biology, University of Kyoto, Japan; and.
  • Hellstrom-Lindberg E; Division of Hematology, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Cazzola M; Department of Molecular Medicine, University of Pavia & Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Blood ; 136(2): 157-170, 2020 07 09.
Article em En | MEDLINE | ID: mdl-32347921
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Medula Óssea / Síndromes Mielodisplásicas / Eritropoese / Fatores de Processamento de RNA / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Medula Óssea / Síndromes Mielodisplásicas / Eritropoese / Fatores de Processamento de RNA / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália